EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries
- 1 February 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 141 (4) , 580-585
- https://doi.org/10.1038/sj.bjp.0705645
Abstract
1. Dilatation of the cerebral vasculature is recognised to be involved in the pathophysiology of migraine. Furthermore, elevated levels of prostaglandin E(2) (PGE(2)) occur in the blood, plasma and saliva of migraineurs during an attack, suggestive of a contributory role. In the present study, we have characterised the prostanoid receptors involved in the relaxation and contraction of human middle cerebral arteries in vitro. 2. In the presence of indomethacin (3 microm) and the TP receptor antagonist GR32191 (1 microM), PGE(2) was found to relax phenylephrine precontracted cerebral arterial rings in a concentration-dependent manner (mean pEC(50) 8.0+/-0.1, n=5). 3. Establishment of a rank order of potency using the EP(4)>EP(2) agonist 11-deoxy PGE(1), and the EP(2)>EP(4) agonist PGE(1)-OH (mean pEC(50) of 7.6+/-0.1 (n=6) and 6.4+/-0.1 (n=4), respectively), suggested the presence of functional EP(4) receptors. Furthermore, the selective EP(2) receptor agonist butaprost at concentrations <1 microM failed to relax the tissues. 4. Blockade of EP(4) receptors with the EP(4) receptor antagonists AH23848 and EP(4)A caused significant rightward displacements in PGE(2) concentration-response curves, exhibiting pA(2) and pK(B) values of 5.7+/-0.1, n=3, and 8.4, n=3, respectively. 5. The IP receptor agonists iloprost and cicaprost relaxed phenylephrine precontracted cerebral arterial rings (mean pEC(50) values 8.3+/-0.1 (n=4) and 8.1+/-0.1 (n=9), respectively). In contrast, the DP and FP receptor agonists PGD(2) and PGF(2 alpha) failed to cause appreciable relaxation or contraction at concentrations of up to 30 microm. In the absence of phenylephrine contraction and GR32191, the TP receptor agonist U46619 caused concentration-dependent contraction of cerebral artery (mean pEC(50) 7.4+/-0.3, n=3). 6. These data demonstrate the presence of prostanoid EP(4) receptors mediating PGE(2) vasodilatation of human middle cerebral artery. IP receptors mediating relaxation and TP receptors mediating contraction were also functionally demonstrated.Keywords
This publication has 53 references indexed in Scilit:
- Correction to “Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2”Molecular Pharmacology, 2003
- Magnetic Resonance Angiography in Facial and other Pain: Neurovascular Mechanisms of Trigeminal SensationJournal of Cerebral Blood Flow & Metabolism, 2001
- Pharmacological characterization of [3H]‐prostaglandin E2 binding to the cloned human EP4 prostanoid receptorBritish Journal of Pharmacology, 2000
- Acute Treatment of Migraine Attacks: Efficacy and Safety of A Nonsteroidal Anti-Inflammatory Drug, Diclofenac-Potassium, in Comparison To Oral Sumatriptan and PlaceboCephalalgia, 1999
- Exclusive expression of the Gs‐linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM‐3 cells and coexpression of subtype 4 and 2 mRNA in U‐937 cellsFEBS Letters, 1996
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Multiple mechanisms for the effects of capsaicin, bradykinin and nicotine on CGRP release from trachcal afferent nerves: Role of prostaglandins, sympathetic nerves and mast cellsNeuropharmacology, 1994
- Increase in PGE2 and TXA2 in the Saliva of Common Migraine Patients. Action of Calcium Channel BlockersHeadache: The Journal of Head and Face Pain, 1989
- Relevance of Prostaglandins in True Menstrual MigraineHeadache: The Journal of Head and Face Pain, 1989
- Brain Stem Terminations of the Trigeminal and Upper Spinal Ganglia Innervation of the Cerebrovascular System: WGA-HRP Transganglionic StudyJournal of Cerebral Blood Flow & Metabolism, 1988